RUO
Studied in selective GH-release research.
Catalog · Research summary
Sermorelin
Sermorelin is a synthetic peptide identical to the first 29 amino acids of GHRH, the shortest sequence with full activity.
- CLASS
- GHRH (1–29) analog
- FORM
- Lyophilized powder
- PAPERWORK
- Certificate of analysis provided with every batch
- STORAGE
- −20 °C, dry, away from light
What it is
Sermorelin is a synthetic peptide identical to the first 29 amino acids of GHRH, the shortest sequence with full activity.
What researchers have studied
Sermorelin has been studied in pituitary GH research. Published work includes:
- Pituitary GH release in pharmacology studies
- GH-axis feedback research
- Age-related changes in GH output
GH Axis
Peptides that act on the growth-hormone axis, studied for how they affect GH release in laboratory models.
This page summarizes published laboratory and animal (preclinical) research for educational purposes only. It is not a claim of safety or effectiveness in people. Sermorelin from Helix RUO will be sold strictly for in-vitro laboratory research. Not evaluated by the FDA. Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease.
Related research peptides
Studied in GHRH-receptor signaling research.